DENVER, Colo., Aug 13, 2025 (247marketnews.com)- As Wall Street tunes into the future of biomaterials, investors are sizing up Bolt Projects (NASDAQ:BSLK), which is one3 of today’s top market movers, and Kraig Biocraft Laboratories (OTCQB:KBLB).
On the surface, both companies tout sustainable innovation, but only one is delivering on scalability, verified strength, and real-world deployment of high-performance fibers. In fact, after Bolt raised funds on the back of Kraig’s success, it pivoted to so-called “vegan silk”.
Trade This Instead: Kraig Biocraft Laboratories (OTCQB:KBLB)
Real Facilities, Real Super Silk, Real Buyers
KBLB just flipped the switch on operations at its new Southeast Asia production facility, secured via partnership with a local government agency.
“This facility represents a critical step forward in our production capabilities… allowing us to expand our operational footprint while maintaining close control over the quality and consistency of our spider silk,” said CEO Kim Thompson.
Kraig Biocraft is producing silk that’s:
- Stronger than natural spider silk
- More elastic than nylon
- Five times stronger than steel by weight
Its patented silkworm-based platform produces Monster Silk®, Dragon Silk®, and SpydaSilk®, each engineered for specific high-performance markets — from military textiles and medical sutures to performance wear and aerospace applications.
Customers Are Already Lining Up
Kraig is actively engaged in commercial talks with three global players:
- A luxury fashion brand that’s accepted a quote
- A top performance sportswear company with budget already approved
- One of the top 5 athletic equipment producers globally
“Currently, we expect to begin deliveries to these customers in the second half of this year.”
With commercial-grade tensile strength testing already confirmed and recent breakthroughs in doubling gene insert complexity, KBLB isn’t pitching potential it’s scaling reality.
Don’t bet on Bolt Projects (BSLK) — the data isn’t there.
Do consider Kraig Labs (KBLB), with production live, validated performance, protected IP, and deals in motion, it’s emerging as a leader in the $20 billion high-performance fiber market.
Other Stocks Under $5 Catching Fire
A wave of sub-$5 momentum plays are drawing increased attention this week, fueled by earnings, contracts, and biotech breakthroughs:
Momentus (NASDAQ:MNTS) is up after announcing progress on its NASA contract, which aims to demonstrate advanced robotics in orbit. Momentus is now one of only two companies being considered for a major follow-up mission.
X4 Pharmaceuticals (NASDAQ:XFOR) raised $85 million in an upsized private placement to accelerate commercialization of its immune disorder therapies. The raise was led by Coastlands Capital, with backing from Bain Capital Life Sciences, NEA, and others.
Cognition Therapeutics (NASDAQ:CGTX) just received FDA confirmation for its Phase 3 Alzheimer’s trial design. Its drug zervimesine (CT1812) showed 95% reduction in cognitive deterioration vs. placebo. Big biotech potential.
Safety Shot (NASDAQ:SHOT) remains volatile but heavily traded.
Bit Origin (NASDAQ:BTOG) is another heavily traded low-float name, moving on speculative momentum as digital asset stocks regain attention.
Editas (NASDAQ:EDIT) is getting a biotech bump following broader enthusiasm for gene editing and CRISPR technologies.
Surf Air Mobility Inc. (NYSE:SRFM) is still climbing on hopes of scalable electric air travel. Retail enthusiasm continues to push the stock as investors bet on the future of regional e-aviation.
agilon health (NYSE:AGL) is back in focus after a string of analyst upgrades and buyout speculation. Solid fundamentals with a clear growth path in senior-focused healthcare.
WANG & LEE GROUP (NASDAQ:WLGS) is aided by improved visibility and retail chatter.
For additional 247marketnews.com KBLB disclosure https://247marketnews.com/kblb-disclosure/.
The post Morning Market Brief with a Trade This, Not That, as Kraig Labs Spins a Stronger Web appeared first on 24/7 MarketNews.
